Cardiovascular & clot risk
CHA₂DS₂-VASc
Stroke risk factors in atrial fibrillation, with sex category as a risk modifier.
Intended population: Adults with atrial fibrillation or atrial flutter. Treatment requires clinical and bleeding-risk assessment.
- Female sex alone is not an indication for anticoagulation. Absolute annual stroke rates vary by cohort and are not estimated here.
- Do not use this score alone for mechanical heart valves or rheumatic moderate/severe mitral stenosis; those require a separate anticoagulation pathway.
- Review bleeding risks, contraindications, renal function, interactions, and patient preferences; this calculator does not select or dose medication.
Sources and scoring references
2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline ↗Implementation references reviewed October 28, 2026. Verify applicability and unusual or treatment-changing results against the linked references and local guidance.
